Trials / Unknown
UnknownNCT05753865
A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound)
A Multicenter, Randomized, Double-blind Phase Ш Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound)
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 454 (estimated)
- Sponsor
- CSPC Ouyi Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to evaluate the efficacy and safety in patients with advanced breast cancer treated with SYHX2011 versus paclitaxel for injection (albumin-bound).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SYHX2011 | IV infusion, 260 mg/m\^2 |
| DRUG | Paclitaxel for injection (albumin-bound) | IV infusion, 260 mg/m\^2 |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2024-09-01
- Completion
- 2024-09-01
- First posted
- 2023-03-03
- Last updated
- 2023-03-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05753865. Inclusion in this directory is not an endorsement.